Skip Navigation



Hum. Reprod. Advance Access published online on September 30, 2005
Human Reproduction, doi:10.1093/humrep/dei311
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/1/80    most recent
dei311v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tang, T.
Right arrow Articles by Balen, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, T.
Right arrow Articles by Balen, A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
Received April 25, 2005
Revised June 29, 2005
Accepted June 30, 2005

Article

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

Thomas Tang 1, Julie Glanville 1, Catherine J. Hayden 1, Davinia White 2, Julian H. Barth 3, and Adam H. Balen 1*

1 Department of Reproductive Medicine, Clarendon Wing, The General Infirmary, Leeds LS2 9NS, UK
2 Department of Reproductive Medicine, St Mary’s Hospital, London W2
3 Department of Clinical Biochemistry, The General Infirmary, Leeds LS1 3EX, UK

* To whom correspondence should be addressed.
Adam H. Balen, E-mail: Adam.balen{at}leedsth.nhs.uk


  Abstract

BACKGROUND: It has been reported that women with polycystic ovary syndrome (PCOS) benefit from metformin therapy. METHODS: A randomized, placebo-controlled, double-blind study of obese (body mass index >30 kg/m2), oligo-/amenorrhoeic women with PCOS. Metformin (850 mg) twice daily was compared with placebo over 6 months. All received the same advice from a dietitian. The primary outcome measures were: (i) change in menstrual cycle; (ii) change in arthropometric measurements; and (iii) changes in the endocrine parameters, insulin sensitivity and lipid profile. RESULTS: A total of 143 subjects was randomized [metformin (MET) = 69; placebo (PL) = 74]. Both groups showed significant improvements in menstrual frequency [median increase (MET = 1, P < 0.001; PL = 1, P < 0.001)] and weight loss [mean (kg) (MET = 2.84; P < 0.001 and PL = 1.46; P = 0.011)]. However, there were no significant differences between the groups. Logistic regression analysis was used to analyse the independent variables (metformin, percentage of weight loss, initial BMI and age) in order to predict the improvement of menses. Only the percentage weight loss correlated with an improvement in menses (regression coefficient = 0.199, P = 0.047, odds ratio = 1.126, 95% CI 1.001, 1.266). There were no significant changes in insulin sensitivity or lipid profiles in either of the groups. Those who received metformin achieved a significant reduction in waist circumference and free androgen index. CONCLUSIONS: Metformin does not improve weight loss or menstrual frequency in obese patients with PCOS. Weight loss alone through lifestyle changes improves menstrual frequency.

Keywords: menstrual frequency/metformin/obese/polycystic ovary syndrome/weight loss.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Pediatr PsycholHome page
D. L. Rofey, E. M. Szigethy, R. B. Noll, R. E. Dahl, E. lobst, and S. A. Arslanian
Cognitive-Behavioral Therapy for Physical and Emotional Disturbances in Adolescents with Polycystic Ovary Syndrome: A Pilot Study
J. Pediatr. Psychol., June 21, 2008; (2008) jsn057v2.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Jensterle, A. Janez, B. Mlinar, J. Marc, J. Prezelj, and M. Pfeifer
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Eur. J. Endocrinol., June 1, 2008; 158(6): 793 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consens
Consensus on infertility treatment related to polycystic ovary syndrome
Hum. Reprod., March 1, 2008; 23(3): 462 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. Moll, F. van der Veen, and M. van Wely
The role of metformin in polycystic ovary syndrome: a systematic review
Hum. Reprod. Update, November 1, 2007; 13(6): 527 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B. Trolle, A. Flyvbjerg, U. Kesmodel, and F.F. Lauszus
Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial
Hum. Reprod., November 1, 2007; 22(11): 2967 - 2973.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. H Balen and A. J Rutherford
Managing anovulatory infertility and polycystic ovary syndrome
BMJ, September 29, 2007; 335(7621): 663 - 666.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba
Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. M. Nelson and R. F. Fleming
The preconceptual contraception paradigm: obesity and infertility
Hum. Reprod., April 1, 2007; 22(4): 912 - 915.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. S. Legro
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
JAMA, February 7, 2007; 297(5): 509 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
E. Elia, V. Sander, C.G. Luchetti, M.E. Solano, G. Di Girolamo, C. Gonzalez, and A.B. Motta
The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice
Mol. Hum. Reprod., August 1, 2006; 12(8): 475 - 481.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Tang, J. Glanville, N. Orsi, J. H. Barth, and A. H. Balen
The use of metformin for women with PCOS undergoing IVF treatment
Hum. Reprod., June 1, 2006; 21(6): 1416 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. H Balen, M. Dresner, E. M Scott, and J. O Drife
Should obese women with polycystic ovary syndrome receive treatment for infertility?
BMJ, February 25, 2006; 332(7539): 434 - 435.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.